Osteonecrosis News and Research

RSS
JDR releases research report on Osteonecrosis of the jaw

JDR releases research report on Osteonecrosis of the jaw

FDA stops pain drug trial over safety concerns

FDA stops pain drug trial over safety concerns

Denosumab delays skeletal-related side effects in patients with breast cancer and bone metastases

Denosumab delays skeletal-related side effects in patients with breast cancer and bone metastases

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Merck wins third FOSAMAX bellwether trial

Merck wins third FOSAMAX bellwether trial

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Denosumab superior to Zometa in preventing SREs in breast cancer patients with bone metastases: Study

Denosumab superior to Zometa in preventing SREs in breast cancer patients with bone metastases: Study

Amgen wins Scrip Best New Drug award for Prolia

Amgen wins Scrip Best New Drug award for Prolia

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Amgen to present oncology portfolio results at ESMO Congress

Amgen to present oncology portfolio results at ESMO Congress

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Tasigna receives approval for chronic myeloid leukemia in Canada

Tasigna receives approval for chronic myeloid leukemia in Canada

BCF publishes two new patient publications

BCF publishes two new patient publications

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck challenges New York jury decision in federal FOSAMAX retrial

One-step surgery positively impacts patient's quality of life: Study

One-step surgery positively impacts patient's quality of life: Study

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Positive results from new analyses of denosumab Phase 3 trials

Positive results from new analyses of denosumab Phase 3 trials

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis